- Main
Head and Neck Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines
- Pfister, David G;
- Spencer, Sharon;
- Brizel, David M;
- Burtness, Barbara;
- Busse, Paul M;
- Caudell, Jimmy J;
- Cmelak, Anthony J;
- Colevas, A Dimitrios;
- Dunphy, Frank;
- Eisele, David W;
- Foote, Robert L;
- Gilbert, Jill;
- Gillison, Maura L;
- Haddad, Robert I;
- Haughey, Bruce H;
- Hicks, Wesley L Jr;
- Hitchcock, Ying J;
- Jimeno, Antonio;
- Kies, Merrill S;
- Lydiatt, William M;
- Maghami, Ellie;
- McCaffrey, Thomas;
- Mell, Loren K;
- Mittal, Bharat B;
- Pinto, Harlan A;
- Ridge, John A;
- Rodriguez, Cristina R;
- Samant, Sandeep;
- Shah, Jatin R;
- Weber, Randal S;
- Wolf, Gregory T;
- Worden, Frank;
- Yom, Sue S;
- McMillian, Nicole;
- Hughes, Miranda
- et al.
Published Web Location
https://doi.org/10.6004/jnccn.2015.0102Abstract
These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types of particle therapy that may be used to treat H&N cancers, in contrast to traditional radiation therapy (RT) with photons (x-ray). Research is ongoing regarding the different types of particle therapy, including protons and carbonions, with the goals of reducing the long-term side effects from RT and improving the therapeutic index. For the 2015 update, the NCCN H&N Cancers Panel agreed to delete recommendations for neutron therapy for salivary gland cancers, because of its limited availability, which has decreased over the past 2 decades; the small number of patients in the United States who currently receive this treatment; and concerns that the toxicity of neutron therapy may offset potential disease control advantages.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-